Capital Investment Counsel, Inc
Source: SEC Form 13F · as of Mar 2026Capital Investment Counsel, Inc holds 10 biotech & pharma companies tracked by BioSniper, totaling $5.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$5.9M
| Company | Shares | Value |
|---|---|---|
| GMEDGlobus Medical Inc. | 20,890 | $1.8M |
| JNJJOHNSON & JOHNSON | 3,848 | $941K |
| LLYELI LILLY & Co | 984 | $905K |
| AMGNAMGEN INC | 2,014 | $709K |
| ABBVAbbVie Inc. | 1,653 | $360K |
| BMYBRISTOL MYERS SQUIBB CO | 5,813 | $353K |
| PFEPFIZER INC | 10,572 | $297K |
| GILDGILEAD SCIENCES, INC. | 2,050 | $286K |
| ABTABBOTT LABORATORIES | 2,376 | $244K |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 18,325 | $15K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.